Mark Wong Selected Research

Mark Wong Research Topics

Disease

13	Neoplasms (Cancer) 04/2022 - 06/2004
3	Lymphoma (Lymphomas) 04/2022 - 01/2017
2	Mycosis Fungoides 04/2022 - 11/2021
2	Hot Flashes 08/2019 - 01/2016
2	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2016
2	Thrombocytopenia (Thrombopenia) 10/2017 - 09/2012
2	Colorectal Neoplasms (Colorectal Cancer) 05/2017 - 01/2017
2	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2005
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2022
1	Rectal Neoplasms (Rectal Cancer) 11/2021
1	Carcinoma (Carcinomatosis) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Hepatitis B 01/2019
1	Coinfection 01/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Hyperpigmentation 01/2019
1	Hepatitis 01/2019
1	Peritonitis 11/2018
1	Hepatic Encephalopathy 11/2018
1	Subacute Combined Degeneration 05/2018
1	Angioedema 01/2018
1	Pulmonary Embolism 10/2017
1	Headache (Headaches) 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 10/2017
1	Fatigue 10/2017
1	Adenocarcinoma 10/2016
1	Disease Progression 10/2016
1	Stomach Neoplasms (Stomach Cancer) 10/2016
1	Ovarian Neoplasms (Ovarian Cancer) 05/2014
1	Anemia 09/2012
1	Liver Diseases (Liver Disease) 09/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2012
1	Hypersplenism (Anemia, Splenic) 09/2012
1	End Stage Liver Disease 09/2012
1	Hypothermia 08/2008
1	Intracranial Hypertension 08/2008

Drug/Important Bio-Agent (IBA)

2	Tamoxifen FDA LinkGeneric 08/2019 - 01/2016
2	4-hydroxy-N-desmethyltamoxifenIBA 08/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
2	TTI-621IBA 02/2017 - 01/2017
1	AntibodiesIBA 04/2022
1	Therapeutic UsesIBA 04/2022
1	InterferonsIBA 11/2021
1	LigandsIBA 01/2021
1	AntigensIBA 01/2020
1	IronIBA 01/2019
1	Hepatitis B e AntigensIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	Rifaximin (L 105)FDA Link 11/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	icatibantIBA 01/2018
1	epidermal growth factor receptor VIIIIBA 10/2017
1	rindopepimutIBA 10/2017
1	Temozolomide (Temodar)FDA LinkGeneric 10/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 10/2017
1	RNA (Ribonucleic Acid)IBA 05/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Biological ProductsIBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	regorafenibIBA 10/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2014
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	Mannitol (Osmitrol)FDA LinkGeneric 08/2008
1	Pentobarbital (Nembutal)FDA Link 08/2008
1	Hemostatics (Antihemorrhagics)IBA 08/2008
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2006
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2005
1	Indicators and Reagents (Reagents)IBA 01/2005
1	Technetium (Technetium 99m)IBA 01/2005
1	Pharmaceutical PreparationsIBA 06/2004
1	Cytochrome P-450 CYP3AIBA 06/2004

Therapy/Procedure

5	Therapeutics 04/2022 - 09/2012
5	Drug Therapy (Chemotherapy) 11/2021 - 01/2005
3	Immunotherapy 04/2022 - 10/2017
1	Radiotherapy 11/2021
1	Proctectomy 11/2021
1	Drug Tapering 08/2019
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Gluten-Free Diet 05/2018
1	Intradermal Injections 10/2017
1	Stents 09/2012
1	Transjugular Intrahepatic Portasystemic Shunt 09/2012
1	Decompression 09/2012
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 09/2012